ARX's CoSign(R) Electronic Signatures Delivered with DataLabs Site Manager(TM) 2.0.

PHILADELPHIA -- Algorithmic Research (ARX), a leading provider of electronic signatures and data security solutions, today announced the integration of its CoSign electronic signature solution with DataLabs' Site Manager 2.0 collaboration software to increase clinical trial efficiency, reduce expense and comply with stringent regulations worldwide.

"CoSign allows clinical trial sponsors and CROs to electronically complete, approve, sign and manage many required documents," says Zikria Syed, VP Product Management, Collaboration Solutions, DataLabs. "Participants can electronically sign and submit these documents in real-time without generating a hard copy as the source document." Enhanced electronic collaboration results, increasing the efficiency and accuracy of data capture.

"CoSign's electronic signature solution integrates seamlessly with Microsoft(R)'s Active Directory allowing customers in the biopharmaceutical market to move from paper-based to electronic business processes without additional system administration," says Steve Shihadeh, General Manager, Healthcare and Life Sciences at Microsoft. "Their use of Microsoft technology enables increased user acceptance and improved efficiency, helping people to better connect and collaborate as well as make more informed business decisions. "

CoSign enhances Microsoft support for electronic signatures through its development of graphical signatures, multiple signatures and sectional signing, benefiting customers challenged with multiple approval processes and 21 CFR Part 11 compliance. With Microsoft's built-in Certificate Authority, CoSign eliminates the PKI management burden.

"Integration will benefit sponsors and CROs," says Rodd Schlerf, Life Sciences Practice Manager, ARX. "This solution reduces the time for site initiation, drives greater control and reduces costs associated with regulatory compliance and record retention of ongoing trial activities."

ARX is an exhibitor at the DIA Annual Meeting on June 18-21, 2006. Schlerf will speak on electronic signatures in the pharmaceutical industry on Wednesday June 21, 8:30 a.m.

About CoSign(R)

CoSign(R) is an electronic signature solution. Based on standard PKI technology, CoSign guarantees signer authenticity, data integrity, and non-repudiation of electronic documents. With CoSign's standard electronic signatures, organizations can sign and seal electronic documents, expedite business processes, reduce costs, increase security and comply with regulations.

CoSign electronic signature solution supports all major applications and file formats (Word, Excel, Outlook, PDF, TIFF, AutoCAD, InfoPath and many more). With a rapid deployment, unique centralized approach, built-in integration with an organization's existing user-management directory systems, and extensive third-party application support, CoSign guarantees a quick ROI.

For more information, visit www.arx.com